Utilization of palliative care in patients hospitalized with heart failure: A contemporary national perspective

Fahad Alqahtani, Sudarshan Balla, Ahmed Almustafa, George Sokos, Mohamad Alkhouli

Research output: Contribution to journalArticle

Abstract

Background: Despite advances in therapy, heart failure (HF) patients have significant symptom burden and poor quality of life. However, data on palliative care (PC) utilization in this population are scarce. We sought to assess national trends in PC utilization in patients admitted with acute HF. Methods: Adults hospitalized with HF without acute coronary syndrome were identified in the National inpatient sample. PC was identified using ICD-9-CM-Code V66.7. Trends in PC utilization, its predictors and its association with length-of-stay and cost were assessed. Results: A total of 939 680 HF patients were hospitalized with HF between 2003 and 2014. Of those,1.2% received PC during the hospitalization, with an upward trend in the use of PC over time (0.12% in 2003 to 3.6% in 2014, P < 0.001). Compared with patients who did not receive PC, those who had PC were older (79 ± 12 vs 69 ± 16 years), and had higher prevalence of Caucasian race (73.4% vs 51.8%), coronary disease (45.6% vs 39.3%), chronic renal disease (79.3% vs 42.8%), and pulmonary hypertension (28.3% vs 15.1%) (P < 0.001). In-hospital mortality (35.2% vs 2.2%), length-of-stay (9 ± 13 days vs 6 ± 6, P < 0.001), cost ($19 984 ± 42 922 vs $11 921 ± 18 175), and non-home discharges (46% vs 19.2%) (P < 0.001) were higher in the PC group. In-hospital mortality in PC group trended downward over time (69% in 2003 vs 29% in 2014, P < 0.001). Conclusion: PC is being utilized in an increasing but overall small number of patients hospitalized with HF. Further research is needed to identify the optimal role and timing of PC in HF patients.

Original languageEnglish (US)
Pages (from-to)136-142
Number of pages7
JournalClinical Cardiology
Volume42
Issue number1
DOIs
StatePublished - Jan 1 2019
Externally publishedYes

Fingerprint

Palliative Care
Heart Failure
Hospital Mortality
Length of Stay
Costs and Cost Analysis
International Classification of Diseases
Acute Coronary Syndrome
Chronic Renal Insufficiency
Pulmonary Hypertension
Coronary Disease
Inpatients
Hospitalization
Quality of Life

Keywords

  • heart failure
  • palliative care

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Utilization of palliative care in patients hospitalized with heart failure : A contemporary national perspective. / Alqahtani, Fahad; Balla, Sudarshan; Almustafa, Ahmed; Sokos, George; Alkhouli, Mohamad.

In: Clinical Cardiology, Vol. 42, No. 1, 01.01.2019, p. 136-142.

Research output: Contribution to journalArticle

Alqahtani, Fahad ; Balla, Sudarshan ; Almustafa, Ahmed ; Sokos, George ; Alkhouli, Mohamad. / Utilization of palliative care in patients hospitalized with heart failure : A contemporary national perspective. In: Clinical Cardiology. 2019 ; Vol. 42, No. 1. pp. 136-142.
@article{f8f8125d0d3042769fa711ec27a38592,
title = "Utilization of palliative care in patients hospitalized with heart failure: A contemporary national perspective",
abstract = "Background: Despite advances in therapy, heart failure (HF) patients have significant symptom burden and poor quality of life. However, data on palliative care (PC) utilization in this population are scarce. We sought to assess national trends in PC utilization in patients admitted with acute HF. Methods: Adults hospitalized with HF without acute coronary syndrome were identified in the National inpatient sample. PC was identified using ICD-9-CM-Code V66.7. Trends in PC utilization, its predictors and its association with length-of-stay and cost were assessed. Results: A total of 939 680 HF patients were hospitalized with HF between 2003 and 2014. Of those,1.2{\%} received PC during the hospitalization, with an upward trend in the use of PC over time (0.12{\%} in 2003 to 3.6{\%} in 2014, P < 0.001). Compared with patients who did not receive PC, those who had PC were older (79 ± 12 vs 69 ± 16 years), and had higher prevalence of Caucasian race (73.4{\%} vs 51.8{\%}), coronary disease (45.6{\%} vs 39.3{\%}), chronic renal disease (79.3{\%} vs 42.8{\%}), and pulmonary hypertension (28.3{\%} vs 15.1{\%}) (P < 0.001). In-hospital mortality (35.2{\%} vs 2.2{\%}), length-of-stay (9 ± 13 days vs 6 ± 6, P < 0.001), cost ($19 984 ± 42 922 vs $11 921 ± 18 175), and non-home discharges (46{\%} vs 19.2{\%}) (P < 0.001) were higher in the PC group. In-hospital mortality in PC group trended downward over time (69{\%} in 2003 vs 29{\%} in 2014, P < 0.001). Conclusion: PC is being utilized in an increasing but overall small number of patients hospitalized with HF. Further research is needed to identify the optimal role and timing of PC in HF patients.",
keywords = "heart failure, palliative care",
author = "Fahad Alqahtani and Sudarshan Balla and Ahmed Almustafa and George Sokos and Mohamad Alkhouli",
year = "2019",
month = "1",
day = "1",
doi = "10.1002/clc.23119",
language = "English (US)",
volume = "42",
pages = "136--142",
journal = "Clinical Cardiology",
issn = "0160-9289",
publisher = "John Wiley and Sons Inc.",
number = "1",

}

TY - JOUR

T1 - Utilization of palliative care in patients hospitalized with heart failure

T2 - A contemporary national perspective

AU - Alqahtani, Fahad

AU - Balla, Sudarshan

AU - Almustafa, Ahmed

AU - Sokos, George

AU - Alkhouli, Mohamad

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Background: Despite advances in therapy, heart failure (HF) patients have significant symptom burden and poor quality of life. However, data on palliative care (PC) utilization in this population are scarce. We sought to assess national trends in PC utilization in patients admitted with acute HF. Methods: Adults hospitalized with HF without acute coronary syndrome were identified in the National inpatient sample. PC was identified using ICD-9-CM-Code V66.7. Trends in PC utilization, its predictors and its association with length-of-stay and cost were assessed. Results: A total of 939 680 HF patients were hospitalized with HF between 2003 and 2014. Of those,1.2% received PC during the hospitalization, with an upward trend in the use of PC over time (0.12% in 2003 to 3.6% in 2014, P < 0.001). Compared with patients who did not receive PC, those who had PC were older (79 ± 12 vs 69 ± 16 years), and had higher prevalence of Caucasian race (73.4% vs 51.8%), coronary disease (45.6% vs 39.3%), chronic renal disease (79.3% vs 42.8%), and pulmonary hypertension (28.3% vs 15.1%) (P < 0.001). In-hospital mortality (35.2% vs 2.2%), length-of-stay (9 ± 13 days vs 6 ± 6, P < 0.001), cost ($19 984 ± 42 922 vs $11 921 ± 18 175), and non-home discharges (46% vs 19.2%) (P < 0.001) were higher in the PC group. In-hospital mortality in PC group trended downward over time (69% in 2003 vs 29% in 2014, P < 0.001). Conclusion: PC is being utilized in an increasing but overall small number of patients hospitalized with HF. Further research is needed to identify the optimal role and timing of PC in HF patients.

AB - Background: Despite advances in therapy, heart failure (HF) patients have significant symptom burden and poor quality of life. However, data on palliative care (PC) utilization in this population are scarce. We sought to assess national trends in PC utilization in patients admitted with acute HF. Methods: Adults hospitalized with HF without acute coronary syndrome were identified in the National inpatient sample. PC was identified using ICD-9-CM-Code V66.7. Trends in PC utilization, its predictors and its association with length-of-stay and cost were assessed. Results: A total of 939 680 HF patients were hospitalized with HF between 2003 and 2014. Of those,1.2% received PC during the hospitalization, with an upward trend in the use of PC over time (0.12% in 2003 to 3.6% in 2014, P < 0.001). Compared with patients who did not receive PC, those who had PC were older (79 ± 12 vs 69 ± 16 years), and had higher prevalence of Caucasian race (73.4% vs 51.8%), coronary disease (45.6% vs 39.3%), chronic renal disease (79.3% vs 42.8%), and pulmonary hypertension (28.3% vs 15.1%) (P < 0.001). In-hospital mortality (35.2% vs 2.2%), length-of-stay (9 ± 13 days vs 6 ± 6, P < 0.001), cost ($19 984 ± 42 922 vs $11 921 ± 18 175), and non-home discharges (46% vs 19.2%) (P < 0.001) were higher in the PC group. In-hospital mortality in PC group trended downward over time (69% in 2003 vs 29% in 2014, P < 0.001). Conclusion: PC is being utilized in an increasing but overall small number of patients hospitalized with HF. Further research is needed to identify the optimal role and timing of PC in HF patients.

KW - heart failure

KW - palliative care

UR - http://www.scopus.com/inward/record.url?scp=85058628863&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058628863&partnerID=8YFLogxK

U2 - 10.1002/clc.23119

DO - 10.1002/clc.23119

M3 - Article

C2 - 30447066

AN - SCOPUS:85058628863

VL - 42

SP - 136

EP - 142

JO - Clinical Cardiology

JF - Clinical Cardiology

SN - 0160-9289

IS - 1

ER -